PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.07%
Negative revenue growth while CX stands at 13.06%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.07%
Negative gross profit growth while CX is at 23.58%. Joel Greenblatt would examine cost competitiveness or demand decline.
-6.07%
Negative EBIT growth while CX is at 89.85%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-6.07%
Negative operating income growth while CX is at 70.77%. Joel Greenblatt would press for urgent turnaround measures.
48.41%
Positive net income growth while CX is negative. John Neff might see a big relative performance advantage.
60.00%
Positive EPS growth while CX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
60.00%
Positive diluted EPS growth while CX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-7.24%
Share reduction while CX is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-7.24%
Reduced diluted shares while CX is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.23%
10Y revenue/share CAGR above 1.5x CX's 9.37%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
14.23%
5Y revenue/share CAGR under 50% of CX's 58.59%. Michael Burry would suspect a significant competitive gap or product weakness.
14.23%
3Y revenue/share CAGR above 1.5x CX's 1.13%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.